Adaptive Designs in Clinical Drug Development

Following the success of last year’s event, the SMi Group’s third annual conference on Adaptive Designs in Clinical Drug Development promises to be better than ever.

As adaptive designs begin to move from theoretical discussion to practical implementation, SMi’s conference will provide a panel of top speakers whose knowledge and experience will give you the edge in your clinical research. Implementing Bayesian statistical models will impact on every part of your drug development, so it will be vital to understand the implications of this change – from the move towards a “learn and confirm” paradigm and the increasing necessity of using EDC and similar technologies, to the changing regulatory environment and the impact on supplies and randomisation in the trials themselves.

Why should you attend this event?

• DISCOVER the latest adaptive trial designs from key statistical experts
• LEARN best practice and important tips for implementing an adaptive trial
• HEAR vital case studies from top pharmaceutical companies
• UNDERSTAND the impact of adaptive techniques on your pipeline and portfolio
• OPTIMISE your knowledge of the regulatory challenges for adaptive clinical trials
• NETWORK with key decision makers and leading specialists

Our expert speaker line-up also includes:

	Micahel Krams, Assistant Vice President, Adaptive Trials, Clinical Development, Wyeth
	David Manner, Group Leader, Endocrine, Exploratory and Programme Medical Statisitcs, Eli Lilly
	Alun Bedding, Director, Biostatistics Development Partners, GlaxoSmithKline

Who should attend?

All those involved in biostatistics, clinical research and portfolio management, including directors, heads and vice presidents of:

• Statistics/Biostatistics
• Clinical R&D
• Medical Affairs
• Clinical Operations
• Clinical Supplies/Logistics
• Data Management
• Portfolio Management
• Regulatory Affairs
• Project Management

Last year’s attendees included representatives of the following companies:

Abbott Amgen Astellas Boehringer Ingelheim BTG Celgene Dainippon Pharmaceuticals Eli-Lilly Genentech GlaxoSmithKline Ipsen Pharmaceuticals

Medimmune Merck & Co. Merck Serono Merz Pharmaceuticals Novartis Teva Sanofi-Sythelabo UCB Wyeth Plus many other delegates from CROs, CTOs, biotechs and academia

Venue details

. Scarsdale Place Kensington London W8 5SR Phone (44) 20 7937 7211, Fax (44) 20 7937 7100, www.millenniumhotels.com